HER2 Testing Characteristics Can Predict Residual Cancer Burden following Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

Figure 1

Patterns of HER2 IHC staining: (a) 100% HER2 IHC staining; (b) >10% and <100% HER2 IHC staining; (c) HER2 IHC 2+ staining.

(a)

(b)

(c)